Urinalysis Market by Product (Consumables, Instruments), Test Type (Biochemical Urinalysis, Sediment Urinalysis), Application, End-Use - Global Forecast 2024-2030

Urinalysis Market by Product (Consumables, Instruments), Test Type (Biochemical Urinalysis, Sediment Urinalysis), Application, End-Use - Global Forecast 2024-2030


The Urinalysis Market size was estimated at USD 4.20 billion in 2023 and expected to reach USD 4.52 billion in 2024, at a CAGR 8.44% to reach USD 7.42 billion by 2030.

Global Urinalysis MarketUrinalysis detects various health conditions such as urinary tract infections, kidney disorders, diabetes, and liver problems. Urinalysis is often used with other diagnostic tools, such as blood and imaging tests, to provide a complete insight into a patient's health status. The increasing incidences of urinary tract infections and kidney disorders, the rising geriatric population, and the growing demand for point-of-care testing have significantly increased the demand for urinalysis. However, in many regions, the reimbursement policies for urinalysis tests are limited or non-existent, which can be a barrier to adoption, particularly for patients who cannot afford the expense of the test. Furthermore, the rapid technological advancement in urinalysis devices to perform multiple urine tests and the integration of AI algorithms to analyze urine samples, identify patterns, and provide insights are expected to provide significant opportunities for the market to grow for years.

Regional Insights

Americas and EMEA are the largest markets for urinalysis products, owing to the high prevalence of diseases such as diabetes, hypertension, and kidney diseases in these regions. China, India, and Japan are also witnessing significant growth in the urinalysis market, driven by increasing healthcare investments and growing awareness about the importance of disease management. The development of the urinalysis market has been boosted by extensive research projects carried out by universities in the US and Canada, which has raised the demand for high-throughput technology solutions in lab processes. Americas region is expected to grow over the forecast period owing to the high investments in R&D and rapid adoption of advanced technological solutions. The urinalysis products market in the Asia-Pacific region is growing steadily in recent years, owing to the factors such as increasing healthcare expenditure, rising awareness about early disease detection, and the growing prevalence of urinary tract infections (UTIs) and kidney diseases.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Urinalysis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Urinalysis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Urinalysis Market, highlighting leading vendors and their innovative profiles. These include 77 Elektronika Kft., Abbott Laboratories, ACON Laboratories, Inc., AdvaCare Pharma, Alphatec Scientific E.I.R.L., Analyticon Biotechnologies GmbH, Anamol Laboratories Pvt. Ltd., ARKRAY, Inc., Beckman Coulter, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Bioway Biotechnology Co., Ltd., Cardinal Health, Inc., Contec Medical Systems Co., Ltd., Dirui Industrial Co., Ltd., EKF DIAGNOSTICS HOLDINGS PLC, Erba Group, F. Hoffmann-La Roche Ltd., Kova International, Inc., MACHEREY-NAGEL GmbH & Co. KG, Medsource Ozone Biomedicals Pvt. Ltd., Quidel Corporation, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthcare GmbH, Sweet Cures Nutra, Sysmex Corporation, Teco Diagnostics, Thermo Fisher Scientific Inc., URIT Medical Electronic Group Co., Ltd, and Woodley Equipment Company Ltd..

Market Segmentation & Coverage

This research report categorizes the Urinalysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Consumables
Instruments
Test Type
Biochemical Urinalysis
Sediment Urinalysis
Application
Diabetes
Hypertension
Kidney Diseases
Liver Diseases
Urinary Tract Infections
End-Use
Clinical Laboratories
Home Healthcare
Hospitals
Research & Academics
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Urinalysis Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Urinalysis Market?
3. What are the technology trends and regulatory frameworks in the Urinalysis Market?
4. What is the market share of the leading vendors in the Urinalysis Market?
5. Which modes and strategic moves are suitable for entering the Urinalysis Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Urinalysis Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of kidney diseases and urinary tract infections worldwide
5.1.1.2. Favorable government initiatives for early screening and management of
chronic diseases
5.1.1.3. Rising adoption of point-of-care urinalysis systems in clinical laboratories and hospitals
5.1.2. Restraints
5.1.2.1. Significant concern for product recall
5.1.3. Opportunities
5.1.3.1. Technological advancement in renal biomarker and smaRT-LAMP system
5.1.3.2. Emergence of automated analyzers for urinary tract infection screening
5.1.4. Challenges
5.1.4.1. Lack of awareness about routine health checkup and limited skilled laboratory workforce
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Urinalysis Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Instruments
7. Urinalysis Market, by Test Type
7.1. Introduction
7.2. Biochemical Urinalysis
7.3. Sediment Urinalysis
8. Urinalysis Market, by Application
8.1. Introduction
8.2. Diabetes
8.3. Hypertension
8.4. Kidney Diseases
8.5. Liver Diseases
8.6. Urinary Tract Infections
9. Urinalysis Market, by End-Use
9.1. Introduction
9.2. Clinical Laboratories
9.3. Home Healthcare
9.4. Hospitals
9.5. Research & Academics
10. Americas Urinalysis Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Urinalysis Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Urinalysis Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Diagnostics Firm Bio-Rad in Talks to Merge with Qiagen
13.3.1.2. FemTec Health Acquires Ava AG, Reproductive Monitoring Pioneer
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Siemens Healthineers and Unilabs Launch Strategic Partnership for Latest Diagnostic Testing Infrastructure to Improve Patients’ Care
13.3.3. New Product Launch & Enhancement
13.3.3.1. 2San Launches Several Home Testing Kits at MEDICA
13.3.3.2. Olive Diagnostics Launches AI-Powered Urinalysis Device
13.3.4. Award, Recognition, & Expansion
13.3.4.1. Medtronic (MDT) Launches New Venture to Treat Kidney Failure
13.3.4.2. Healthy.io Receives FDA Clearance for Smartphone-Based Home Kidney Test
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. 77 Elektronika Kft.
14.1.2. Abbott Laboratories
14.1.3. ACON Laboratories, Inc.
14.1.4. AdvaCare Pharma
14.1.5. Alphatec Scientific E.I.R.L.
14.1.6. Analyticon Biotechnologies GmbH
14.1.7. Anamol Laboratories Pvt. Ltd.
14.1.8. ARKRAY, Inc.
14.1.9. Beckman Coulter, Inc.
14.1.10. Becton, Dickinson, and Company
14.1.11. Bio-Rad Laboratories, Inc.
14.1.12. Bioway Biotechnology Co., Ltd.
14.1.13. Cardinal Health, Inc.
14.1.14. Contec Medical Systems Co., Ltd.
14.1.15. Dirui Industrial Co., Ltd.
14.1.16. EKF DIAGNOSTICS HOLDINGS PLC
14.1.17. Erba Group
14.1.18. F. Hoffmann-La Roche Ltd.
14.1.19. Kova International, Inc.
14.1.20. MACHEREY-NAGEL GmbH & Co. KG
14.1.21. Medsource Ozone Biomedicals Pvt. Ltd.
14.1.22. Quidel Corporation
14.1.23. Randox Laboratories Ltd.
14.1.24. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
14.1.25. Siemens Healthcare GmbH
14.1.26. Sweet Cures Nutra
14.1.27. Sysmex Corporation
14.1.28. Teco Diagnostics
14.1.29. Thermo Fisher Scientific Inc.
14.1.30. URIT Medical Electronic Group Co., Ltd
14.1.31. Woodley Equipment Company Ltd.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. URINALYSIS MARKET RESEARCH PROCESS
FIGURE 2. URINALYSIS MARKET SIZE, 2023 VS 2030
FIGURE 3. URINALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. URINALYSIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. URINALYSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. URINALYSIS MARKET DYNAMICS
FIGURE 7. URINALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. URINALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. URINALYSIS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 10. URINALYSIS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. URINALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. URINALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. URINALYSIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. URINALYSIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES URINALYSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES URINALYSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. URINALYSIS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. URINALYSIS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings